Drug intelligence / Profile preview

terpene-enriched cannabis oil

Development stage
Phase 2
Lead developer
Bazelet Pharma
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Sublingual
01

Overview

Terpene-enriched cannabis oil is an investigational medical cannabis formulation developed by Bazelet to address the loss of volatile terpenes that occurs during standard extraction processes. Standard cannabis extraction often depletes up to 90% of the plant's natural monoterpenes and monoterpenoids, potentially reducing the therapeutic efficacy of the resulting oil compared to inhaled inflorescences (the 'entourage effect'). By re-introducing specifically selected terpenes into the cannabinoid-standardized oil, this formulation aims to restore or enhance the synergistic therapeutic effects of the plant. It is being evaluated in clinical trials for the management of chronic pain and acute radicular pain, where it has demonstrated potential opioid-sparing effects.

Other names
terpene-enriched cannabis extractterpene-enriched medical cannabis oil
02

Targets

CNR1 (Cannabinoid receptor 1)PPAR (PPAR family)TRPA1 (Transient receptor potential cation channel subfamily A member 1)TRPV1 (Transient receptor potential cation channel subfamily V member 1)

Beyond the preview

Go deeper on terpene-enriched cannabis oil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on terpene-enriched cannabis oil.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call